Latest Posts

22

Apr 24

Partex Partners with Lupin to Revolutionize Drug Discovery through AI-Driven Asset Search and Evaluation

Frankfurt, Germany, 23 April 2024 – Partex, a leading provider of AI-driven solutions in the pharmaceutical industry, is thrilled to...
Read More

27

Mar 24

Partex NV announces collaboration with Althea DRF Lifesciences to provide comprehensive end-to-end services to accelerate drug discovery and development

Frankfurt, Germany; 28 March 2024 – Partex Group, a pioneer in AI-driven drug discovery, announces a collaboration with Althea DRF...
Read More

Innoplexus wins Horizon Interactive Gold Award for Curia App

Read More

Category: news older

How The Ethereum [ETH] Blockchain Is Powering The Next Generation Of Pharma Innovation

Ask the average person about the blockchain, and you’d be lucky if one in ten could tell you – even in vague terms – how the technology works, or even what it is. Buzzwords like Bitcoin will probably be uttered, but aside from cryptocurrencies, understanding of practical uses for blockchain technology has yet to hit …

How The Ethereum [ETH] Blockchain Is Powering The Next Generation Of Pharma Innovation Read More »

Blockchain and AI-based Platform iPlexus to Revolutionize Drug Discovery

Innoplexus AG announced a revolutionary update is coming soon to their iPlexus platform that will harness the power of blockchain technology and artificial intelligence to weed out wastefulness in early-stage drug discovery. iPlexus is a one-stop deep data ocean of relevant information for the pharmaceutical industry. It uses the power of Blockchain and AI to …

Blockchain and AI-based Platform iPlexus to Revolutionize Drug Discovery Read More »

German Blockchain, AI Platform to ‘Democratize’ Drug Development

Germany-based company Innoplexus AG said that iPlexus (one of its subsidiaries) will leverage blockchain technology and AI to resolve inefficiencies in early-stage drug discovery. The company also has its offices in Pune, India and Hoboken in the United States of America. The subsidiary will give researchers a secure, blockchain-and-AI-based platform for publishing and extending license …

German Blockchain, AI Platform to ‘Democratize’ Drug Development Read More »

Innoplexus’s New North American Affiliate is Bringing AI Innovation to the US Pharma Industry

It’s no secret that the American pharma industry is facing its fair share of challenges. From rising drug prices to corruption charges, the issues that American pharmaceutical companies face today demand innovative solutions. Fortunately, a leading pharmaceutical innovation company is hoping to deliver these solutions with the launch of their North American affiliate. Innoplexus AG …

Innoplexus’s New North American Affiliate is Bringing AI Innovation to the US Pharma Industry Read More »

Innoplexus Proudly Announces the Launch of its Product iPlexus, at Bio-IT World, 2017

Innoplexus unveiled iPlexus at Bio-IT, 2017, Boston. iPlexus.ai is an end-to-end platform for Life Sciences which leverages Artificial Intelligence (AI) to cut the drug development time, from synthesis to approval, significantly. It generates continuous intelligence and insights, across discovery, clinical development, regulatory and commercial stages of drug development, spanning all major therapeutic areas and indications. …

Innoplexus Proudly Announces the Launch of its Product iPlexus, at Bio-IT World, 2017 Read More »

Innoplexus featured on Inc.

3 Ways Big Data and Analytics are Making Big Changes in Healthcare The technologies behind the next wave in healthcare innovation. Information is the new currency of innovation. With data flowing from countless new sources every day, the opportunities to dig in and learn more about the world around us have never been greater. Sometimes …

Innoplexus featured on Inc. Read More »